ARTICLE | Company News
Kaslow leaves Merck to lead PATH Malaria initiative
March 2, 2012 1:54 AM UTC
David Kaslow stepped down as VP and head of vaccines project leadership and management at Merck & Co. Inc. (NYSE:MRK) to become the director of the PATH Malaria Vaccine Initiative. ...